- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04885608
PReGe in Outdoor Fitness Parks (PReGe-BIO)
November 3, 2021 updated by: Fausto Jose Barbero-Iglesias, University of Salamanca
Therapeutic Exercise for Older Adults: Revitalization and Postural Balance in Outdoor Fitness Parks
Older people have been one of the most affected by the Covid-19 pandemic.
Restrictive measures to prevent the spread of the virus have affected the lifestyle of older people, which have reduced their level of physical activity.
A sedentary lifestyle has negative health consequences, such as increased frailty and decreased functional capacity.
The aim of the study is to apply a program of therapeutic exercise in outdoor fitness parks to prevent the complications of sedentary lifestyle.
Community-dwelling older adults belonging will participate in an outdoor program to keep security measures and prevent contagion.
Study Overview
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Salamanca, Spain, 37007
- Universidad de Salamanca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- People over 60 year who decide to participate voluntarily.
- Acceptance of Informed Consent.
- Municipal registration in Salamanca.
- Responsible declaration of good health.
- Absence of symptoms compatible with Covid-19.
Exclusion Criteria:
- Presence of absolute or relative contraindications to physical exercise.
- Presence of serious balance limitations, such as severe neurological, visual or musculoskeletal disorders.
- Presence of difficulties to carry out the tests of the Initial Assessment.
- Participate in another physical activity program.
- Incidents or pathologies suffered during the intervention that interfere with the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PReGe
Group that will perform the intervention with therapeutic exercise.
|
There will be two weekly sessions of 45 minutes, outdoors in outdoor fitness parks.
The components of balance, gait, resistance, strength and elasticity will be worked on and breathing exercises will be performed.
The sessions will be guided and dosed by physiotherapists, considering the level of perception of effort.
Indications will be given to carry out other sessions of 60 to 120 minutes of therapeutic walking (minimum speed of 4 km/hour) during the week, to complete the 150-300 minutes per week of physical activity recommended by the WHO.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Physical Performance Battery (SPPB)
Time Frame: Change from baseline to 16 weeks follow-up.
|
A validated test to identify frail older adults. The score ranges from 0 to 12 points. The lowest scores are for people with the highest degree of frailty. |
Change from baseline to 16 weeks follow-up.
|
|
2 minute stair test
Time Frame: Change from baseline to 16 weeks follow-up.
|
Test that evaluates cardiorespiratory endurance.
There are reference tables that provide a percentile of resistance based on the age and gender of the participant.
|
Change from baseline to 16 weeks follow-up.
|
|
Borg Rating of Perceived Exertion Scale
Time Frame: Change from baseline to 16 weeks follow-up.
|
Exertion rating based on a 6 to 20 rating scale may provide a fairly good estimate of the actual heart rate during physical activity. Higher scores imply a greater degree of perceived exertion. |
Change from baseline to 16 weeks follow-up.
|
|
IPAQ-E Questionnaire
Time Frame: Change from baseline to 16 weeks follow-up.
|
Questionnaire that evaluates the level of physical activity.
The time spent on activities of different intensity during the last 7 days is recorded.
The score is calculated in METs-minute-week (MMW).
METs refer to a metabolic expenditure rate.
A greater number of MMW, greater amount of physical activity is done weekly.
|
Change from baseline to 16 weeks follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sex
Time Frame: Baseline
|
Participant's sex will be registered.
|
Baseline
|
|
Date of birth
Time Frame: Baseline
|
Participant's date of birth will be recorded in order to calculate their age.
|
Baseline
|
|
Medication
Time Frame: Baseline
|
Information on the medication that each participant is currently taking will be collected to evaluate possible interferences.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Fausto J Barbero-Iglesias, PhD, University of Salamanca
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2021
Primary Completion (Actual)
August 27, 2021
Study Completion (Actual)
August 27, 2021
Study Registration Dates
First Submitted
May 8, 2021
First Submitted That Met QC Criteria
May 12, 2021
First Posted (Actual)
May 13, 2021
Study Record Updates
Last Update Posted (Actual)
November 11, 2021
Last Update Submitted That Met QC Criteria
November 3, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- PReGeUSAL-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frail Elderly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
Aalborg University HospitalUniversity of Copenhagen; Hvidovre University Hospital; Amager Hospital; Aalborg...Completed
-
Université Catholique de LouvainFonds National de la Recherche ScientifiqueCompletedFrail Elderly InpatientBelgium
-
University of ManitobaTerminated
-
McMaster UniversityCanadian Frailty NetworkCompleted
-
Health Center of the City of JoensuuUnknown
-
Marmara UniversityEnrolling by invitationFrail ElderlyTurkey (Türkiye)